MedPath

Synanthic Bovine Dewormer

(oxfendazole oral suspension)

Approved
Approval ID

152cde64-ff22-4a3e-bb78-65e159dbe6b6

Product Type

OTC ANIMAL DRUG LABEL

Effective Date

May 1, 2025

Manufacturers
FDA

Boehringer Ingelheim Animal Health USA Inc.

DUNS: 007134091

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

oxfendazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0010-3832
Application NumberNADA140854
Product Classification
M
Marketing Category
C73593
G
Generic Name
oxfendazole
Product Specifications
Route of AdministrationORAL
Effective DateMay 1, 2025
FDA Product Classification

INGREDIENTS (1)

OXFENDAZOLEActive
Quantity: 225 mg in 1 mL
Code: OMP2H17F9E
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Synanthic Bovine Dewormer - FDA Drug Approval Details